Dr. Brad Reinfeld, MD PhD

No child deaths have been definitively linked to Covid vaccines, according to a report from the FDA that was quietly made public. nbcnews.com/health/health-…

This is insane lol

.@CharlesRudin named cancer center director at @MSKCancerCenter cancerletter.com/in-brief/20260…

@MichaelR21 first appearance of many at @MSKCancerCenter…. Great talk by @datsunian

Retatrutide, a triple receptor drug for GLP-1, GIP, and glucagon, is the most powerful weight loss drug yet. A significant issue is too much weight loss among the trial participants. New randomized trial results announced today with 28% body weight loss. gift link nytimes.com/2026/05/21/sci…

Timely analysis from the trial that led to the approval of the first tumor-agnostic HER2-directed therapy in patients with HER2 IHC 3+ advanced solid tumors, including advanced urothelial carcinoma. Discordance between local & central HER2 IHC scoring highlights the need for a standardized scoring system not only to identify patients eligible for Enhertu, but also those with HER2 IHC 1+/2+/3+ expression who may be eligible for the growing number of HER2-directed clinical trials. aacrjournals.org/clincancerres/… @OncoAlert @jamecancerdoc @koshkin85 @OncBrothers @DrKarineTawagi @CanDAydogdu @LauraBukavinaMD @emanuele_crupi @DanieleRaggi83 @niklas_kluemper @PTarantinoMD @Uromigos

The AACR-Exelixis Renal Cell Carcinoma Research Fellowship provides $130,000 over two years to support postdoctoral or clinical research fellows. Research must have direct applicability and relevance to renal cell carcinoma. Apply by June 11: brnw.ch/21x2Fxu

We're highlighting hematology-oncology fellows Eileen Shiuan, MD, PhD and Lisa Shiliang Zhang, MD who presented research at the American Association for Cancer Research Annual Meeting. Learn how their work is breaking new ground in the oncology field: uclahs.fyi/48XcMc2

Get your VIP tickets now for The CheckPoints: Rockin’ for a Cure, May 31 at Buddy Guy’s Legends in Chicago, while supplies last. Space is limited. Proceeds benefit the next generation of cancer immunotherapy luminaries through SITC’s Forward Fund. sitcancer.org/about/the-chec…

We are hiring! We are specifically looking for a postgraduate associate - someone who has recently finished university and is ultimately looking to apply to medical school or graduate school. It is a TWO YEAR clinical/translational position, where you will be interacting closely with patients, involved in translational clinical trials, and working hands on in the lab and with clinical databases. The ideal candidate is a great communicator, organized, and enthusiastic about patient-oriented clinical and lab research. You will get dedicated mentoring not just on the science and clinic, but also on career/professional development as well. We are looking for someone to start ASAP! More information here: postdocs.yale.edu/posts/2026-01-… Please help to spread the word and RT! @DrChoueiri @VanAllenLab @tompowles1 @YaleCancer @YaleMed @SmilowCancer @kidneycan @OncoAlert @OncLive @KidneyCancer @A_P_S_A @cure_today @yalepathology @Yale_Urology @DrYukselUrun @MarkDSiegel1 @OncBrothers @DrKarineTawagi

@fabermdphd So the OnPro should be set for 72 hours. Seems easy….

Well, this is intriguing and easy enough to do...and could save those on-call fellows some extra work pubmed.ncbi.nlm.nih.gov/41871353/

Check out Dr. Abel's Q&A with the Proceedings of the National Academy of Sciences!  He dives into his research on cardiac metabolism in heart failure, the role of mitochondrial dysfunction and the importance of rigor in the field: pnas.org/doi/10.1073/pn…

Want SITC Swag? Go to ondemand.sitcancer.org & log in to your SITC account and watch OnDemand videos by May 27! You will be entered into a drawing for SITC Swag! Become a SITC Member or purchase a subscription and explore 1,300+ SITC IO videos. More at: sitcancer.org/ondemand

@Aiims1742 @charlesrudin @MSKCancerCenter @rosslevinemd Congrats! We were in clinic this am!

Congratulations to @charlesrudin the NEW Cancer Center Director at @MSKCancerCenter (just announced a few hours ago!) Happy to be at the NYC corner of the Cancer Center Directors’s dinner in DC. @rosslevinemd

A perk of training in NYC with a dog…. 🐶

Super excited to share my latest work that harnesses our recently described aspartate biosensor to highlight the importance of consistent, temporal metabolite measurements in response to metabolic perturbations. Lots of new and exciting finds! Thread below by @LucasBSullivan

Former President Barack Obama endorses Jen Jordan and Miracle Rankin, the Democratic-backed challengers seeking to oust Georgia Supreme Court justices Charlie Bethel and Sarah Warren in the May 19 vote. Former VP Kamala Harris earlier endorsed Jordan and Rankin, too. #gapol

Genomic/transcriptomic alterations in advanced NENs 168 patients with advanced, treatment-refractory NENs. Whole genome/exome and RNA seq. Too much info to detail here and perhaps not a whole lot of ned data but NGS can lead to revised diagnosis such as in the cases of EWSR1 fusions. Also, almost 10% have germline alterations. 86% of patients received molecularly guided therapy recommendations but I find that to be very high and and I think we need to be clear on what is truly actionable and relevant in this disease. Benefit was also seen in those who had such therapy but then, benefit is often seen in those who have empiric later-lines therapy. That all said, an excellent addition to the literature. sciencedirect.com/science/articl…

GET READY TO ROCK! 🎸🥁🎺🎶The CheckPoints are playing @BuddyGuys Sun during @ASCO. Buy VIP tix now- support the next gen of cancer IO experts. Proceeds benefit @sitcancer Forward Fund! @PatrickHwuMD @jasonlukemd @BReinfeld ow.ly/KOER50YWETq

Powerful editorial on corporitization of medicine. 1. Trainees are not cheap labor 2. Margin focus threatens trust. 3. Leaders need to stay in touch with clinical care nejm.org/doi/full/10.10…